India to Kenya Pharmaceutical Export (2026) — $588.0M, 687 Suppliers | TransData Nexus

India to Kenya Pharmaceutical Export (2026) — $588.0M, 687 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Kenya

#	Formulation	Value	Share
1	Typbar Tcv-2.5 ML Vial	$28.7M	4.9%
2	Roxone 1gm: (ceftriaxone Injection USP 1	$28.1M	4.8%
3	Temtrin ( Artemether 20mg & Lumefantrine	$20.7M	3.5%
4	Aceclofenac 100 MG + Paracetamol 500 MG	$12.6M	2.1%
5	Lamivudine 150mg + Zidovudine 300mg Tablets (60s) (38974 Pakc X 60s = 2338440no…	$11.2M	1.9%
6	Pharmaceutical Goods/harmless Medicines	$10.9M	1.9%
7	Abacavir Sulfate 600mg + Lamivudine 300mg Tablets (30s) (39524 Pack X 30s = 118…	$7.9M	1.4%
8	Abacavir Sulfate 600mg + Lamivudine 300mg Tablets (30s) (38635 Packs X 30s=1159…	$7.8M	1.3%
9	Pharma Drugs and Medi Losartas-ht As Per	$7.2M	1.2%
10	Kuartem Tablets 20/120 Artemether 20mg &	$6.8M	1.2%
11	Flonart 120 MG Artesunate for Injection	$6.3M	1.1%
12	Esgame 20/120 Tablet (artemether 20mg +	$6.2M	1.1%
13	Abacavir Sulfate 600mg + Lamivudine 300mg Tablets (30s) (28116 Pack X 30s = 843…	$5.7M	1.0%
14	Tenofovir Disoproxil Fumarate 300mg + Lamivudine 300mg Tablets (30s) (67322 Pac…	$5.3M	0.9%
15	Kuartem Tablets 80/480 Artemether & Lume	$4.9M	0.8%

India exports 20+ pharmaceutical formulations to Kenya with a combined trade value of $588.0M. Key products include Ceftriaxone ($28.1M), Artemether ($20.7M), Paracetamol ($12.6M), Artesunate ($6.3M), Tenofovir ($5.3M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 38,476 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Kenya Trade Routes

1Ceftriaxone$28.1M 2Artemether$20.7M

3Paracetamol$12.6M

4Artesunate$6.3M 5Tenofovir

Top Indian Exporters to Kenya

1Mylan Laboratories Limited

$70.9M

2Innova Captab Limited

$57.0M

3Bharat Biotech International Limited

$38.5M

4Afroway Pharma

$36.9M

5Intas Pharmaceuticals Limited

Port Analysis — India to Kenya Pharmaceutical Shipments

Indian Export Ports

AHEMDABAD ICD3.7%

NHAVA SHEVA SEA (INNSA1)12.3%

GRFL SAHNEWAL LUDHIANA ICD0.7%

HYDERABAD ACC (INHYD4)0.3%

JNPT/ NHAVA SHEVA SEA5.7%

Kenya Import Ports

Mombasa13.6%

NAIROBI48.4%

MOMBASA19.3%

Nairobi4.0%

Kampala4.1%

Trade Statistics

Total Value$588.0M

Shipments38,476

Indian Exporters687

Kenya Buyers1144

Avg Shipment$15K

Products28,813

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Kenya Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Kenya pharmaceutical trade corridor has experienced significant growth over the past decade. Between 2022 and 2026, India exported pharmaceutical products valued at $588 million USD to Kenya, encompassing 38,476 shipments from 687 Indian exporters to 1,144 Kenyan buyers. This surge underscores the strengthening trade relations and India's pivotal role in supplying essential medicines to the East African market.

Key milestones include the establishment of robust distribution networks and the introduction of diverse pharmaceutical formulations tailored to Kenya's healthcare needs. The trade's expansion reflects India's strategic focus on African markets and Kenya's growing demand for quality pharmaceuticals.

2India's Market Position

India holds a dominant position in Kenya's pharmaceutical imports, supplying a substantial portion of the market's needs. This dominance is attributed to India's competitive pricing, adherence to international quality standards, and a comprehensive product portfolio. The strategic importance of this relationship is evident in India's sustained export growth and Kenya's reliance on Indian pharmaceuticals to meet its healthcare demands.

3Recent Developments

FAQ — India to Kenya Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Kenya?

India exported pharmaceuticals worth $588.0M to Kenya across 38,476 verified shipments.

Who are the top Indian pharmaceutical exporters to Kenya?

1. MYLAN LABORATORIES LIMITED — $70.9M. 2. INNOVA CAPTAB LIMITED — $57.0M. 3. BHARAT BIOTECH INTERNATIONAL LIMITED — $38.5M. Total: 687 suppliers.

Which companies in Kenya import pharmaceuticals from India?

1. NATIONAL VACCINES AND IMMUNIZATION — $38.3M. 2. KENYA MEDICAL SUPPLIES — $37.0M. 3. THE MANAGER, — $31.4M. 1144 buyers total.

What pharmaceutical products does India export most to Kenya?

1. Typbar Tcv-2.5 ML Vial ($28.7M, 4.9%); 2. Roxone 1gm: (ceftriaxone Injection USP 1 ($28.1M, 4.8%); 3. Temtrin ( Artemether 20mg & Lumefantrine ($20.7M, 3.5%); 4. Aceclofenac 100 MG + Paracetamol 500 MG ($12.6M, 2.1%); 5. Lamivudine 150mg + Zidovudine 300mg Tablets (60s) (38974 Pakc X 60s = 2338440no… ($11.2M, 1.9%)

Which ports handle pharmaceutical shipments from India to Kenya?

Export: AHEMDABAD ICD, NHAVA SHEVA SEA (INNSA1), GRFL SAHNEWAL LUDHIANA ICD, HYDERABAD ACC (INHYD4), JNPT/ NHAVA SHEVA SEA. Import: Mombasa, NAIROBI, MOMBASA, Nairobi, Kampala.

Why does Kenya import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $588.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Kenya?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Kenya pharmaceutical trade?

$15.3K per consignment across 38,476 shipments.

How many Indian pharmaceutical companies export to Kenya?

687 Indian companies. Largest: MYLAN LABORATORIES LIMITED with $70.9M.

How can I find verified Indian pharmaceutical suppliers for Kenya?

TransData Nexus covers 687 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Kenya identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 38,476 verified shipments from 687 Indian exporters to 1144 Kenya buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

687 Exporters

1144 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Kenya Pharmaceutical Export

Top Pharmaceutical Formulations — India to Kenya

Top Pharmaceutical Products — India to Kenya Trade Routes

Top Indian Exporters to Kenya

Port Analysis — India to Kenya Pharmaceutical Shipments

Indian Export Ports

Kenya Import Ports

Trade Statistics

Other Destinations

India–Kenya Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Kenya Buyers from India

Product Routes

Full Dataset Access

Kenya Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Kenya

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Kenya

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Kenya Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Kenya for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Kenya

1Competing Origins

2India's Competitive Edge

3Challenges & Threats